Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $74.31 ($214K) on 2015-04-01, disclosed to the SEC on 2015-04-03.
Scheduled sale ($214k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.52 | 1,260 | $89K | 41.6% |
| 2 | $71.57 | 1,540 | $110K | 51.6% |
| 3 | $72.65 | 100 | $7K | 3.4% |
| 4 | $74.31 | 100 | $7K | 3.5% |
| Total | $71.26 avg | 3,000 | $214K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |